Literature DB >> 28444739

Incidence and survival trends in mantle cell lymphoma.

Narendranath Epperla1, Mehdi Hamadani1, Timothy S Fenske1, Luciano J Costa2.   

Abstract

Entities:  

Keywords:  incidence; mantle cell lymphoma; population outcomes; relative survival rate; survival

Mesh：

Year:  2017        PMID： 28444739     DOI： 10.1111/bjh.14699

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  22 in total

Review 1.  Management of Older Adults with Mantle Cell Lymphoma.

Authors:  Jason T Romancik; Jonathon B Cohen
Journal:  Drugs Aging       Date:  2020-07       Impact factor: 3.923

Review 2.  Invited Review: Will Consolidation with ASCT Be a Thing of the Past for MCL and PTCL?

Authors:  Alessandro Broccoli; Lisa Argnani; Pier Luigi Zinzani
Journal:  Curr Hematol Malig Rep       Date:  2021-03-01       Impact factor: 3.952

3.  Five-year outcomes of the S1106 study of R-hyper-CVAD vs R-bendamustine in transplant-eligible patients with mantle cell lymphoma.

Authors:  Manali Kamdar; Hongli Li; Robert W Chen; Lisa M Rimsza; Michael L Leblanc; Timothy S Fenske; Thomas C Shea; Paul M Barr; Tycel J Phillips; John P Leonard; Brad S Kahl; Jonathan W Friedberg; Sonali M Smith
Journal:  Blood Adv       Date:  2019-10-22

4.  Lenalidomide in Pretreated Mantle Cell Lymphoma Patients: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice (the Lenamant Study).

Authors:  Vittorio Stefoni; Cinzia Pellegrini; Alessandro Broccoli; Luca Baldini; Monica Tani; Emanuele Cencini; Amalia Figuera; Michela Ansuinelli; Elisa Bernocco; Maria Cantonetti; Maria Christina Cox; Filippo Ballerini; Chiara Rusconi; Carlo Visco; Luca Arcaini; Angelo Fama; Roberto Marasca; Stefano Volpetti; Alessia Castellino; Catello Califano; Marina Cavaliere; Guido Gini; Anna Marina Liberati; Gerardo Musuraca; Anna Lucania; Giuseppina Ricciuti; Lisa Argnani; Pier Luigi Zinzani
Journal:  Oncologist       Date:  2018-04-19

Review 5.  Sequencing of Novel Therapies for Mantle Cell Lymphoma.

Authors:  Jason T Romancik; Jonathon B Cohen
Journal:  Curr Treat Options Oncol       Date:  2021-11-23

6.  Outcomes and Utilization Trends of Front-Line Autologous Hematopoietic Cell Transplantation for Mantle Cell Lymphoma.

Authors:  Peter A Riedell; Mehdi Hamadani; Kwang W Ahn; Carlos Litovich; Guru Subramanian Guru Murthy; Frederick L Locke; Claudio G Brunstein; Reid W Merryman; Patrick J Stiff; Attaphol Pawarode; Taiga Nishihori; Mohamed A Kharfan-Dabaja; Alex F Herrera; Craig S Sauter; Sonali M Smith
Journal:  Transplant Cell Ther       Date:  2021-08-24

7.  Molecular determinants of outcomes in relapsed or refractory mantle cell lymphoma treated with ibrutinib or temsirolimus in the MCL3001 (RAY) trial.

Authors:  Ryan D Morin; David W Scott; Georg Lenz; Ciara L Freeman; Prasath Pararajalingam; Ling Jin; Sriram Balasubramanian; Aixiang Jiang; Wendan Xu; Michael Grau; Myroslav Zapukhlyak; Merrill Boyle; Brendan Hodkinson; Michael Schaffer; Christopher Enny; Sanjay Deshpande; Steven Sun; Jessica Vermeulen
Journal:  Leukemia       Date:  2022-08-13       Impact factor: 12.883

8.  Early relapse identifies MCL patients with inferior survival after intensive or less intensive frontline therapy.

Authors:  David A Bond; Jeffrey M Switchenko; Diego Villa; Kami Maddocks; Michael Churnetski; Alina S Gerrie; Subir Goyal; Krithika Shanmugasundaram; Oscar Calzada; Bhaskar Kolla; Veronika Bachanova; James N Gerson; Stefan K Barta; Brian T Hill; Yazeed Sawalha; Peter Martin; Edward Maldonado; Max Gordon; Alexey V Danilov; Natalie S Grover; Stephanie Mathews; Madelyn Burkart; Reem Karmali; Nilanjan Ghosh; Steven I Park; Narendranath Epperla; Talha Badar; Jin Guo; Mehdi Hamadani; Timothy S Fenske; Mary-Kate Malecek; Brad S Kahl; Christopher R Flowers; Kristie A Blum; Jonathon B Cohen
Journal:  Blood Adv       Date:  2021-12-14

9.  First-Line Autologous Stem Cell Transplantation for Mantle Cell Lymphoma: A Systematic Analysis and Treatment Recommendation.

Authors:  Hailing Liu; Xiao Shi; Huizi Fang; Lei Cao; Yi Miao; Xiaoli Zhao; Wei Wu; Wei Xu; Jianyong Li; Lei Fan
Journal:  Front Oncol       Date:  2022-05-11       Impact factor: 5.738

10.  Intensive induction regimens after deferring initial therapy for mantle cell lymphoma are not associated with improved survival.

Authors:  Krithika Shanmugasundaram; Subir Goyal; Jeffery Switchenko; Oscar Calzada; Michael C Churnetski; Bhaskar Kolla; Veronika Bachanova; James N Gerson; Stefan K Barta; Max J Gordon; Alexey V Danilov; Natalie S Grover; Stephanie Mathews; Madelyn Burkart; Reem Karmali; Yazeed Sawalha; Brian T Hill; Nilanjan Ghosh; Steven I Park; Narendranath Epperla; David A Bond; Talha Badar; Kristie A Blum; Mehdi Hamadani; Timothy S Fenske; Mary Malecek; Brad S Kahl; Peter Martin; Jin Guo; Christopher R Flowers; Jonathon B Cohen
Journal:  Eur J Haematol       Date:  2021-06-17       Impact factor: 2.997
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.